[1] Teicher BA, Menon K, Northey D, et al.Cyclocreatine in cancer chemotherapy[J]. Cancer Chemother Pharmcol, 1995, 35(5): 411-416. [2] Houser SL, Elkerm AF, Wei Z, et al.Enhancement of cardiac function by Cyclocreatine in models of cardiopulmonary bypass[J]. J Mol Cell Cardiol, 1995, 27(4): 1065-1073. [3] Cekici A, Kantarci A, Hasturk H.Inflammatory and immune pathways in the pathogenesis of periodontal disease[J]. Periodontol 2000, 2014, 64(1): 57-80. [4] Hienz SA, Paliwal S, Ivanovski S.Mechanisms of bone resorption in periodontitis[J]. J Immunol Res, 2015: 615486. [5] Chang EJ, Ha J, Oerlemans F, et al.Brain-type creatine kinase has a crucial role in osteoclast-mediated bone resorption[J]. Nat Med, 2008, 14(9): 966-972. [6] Page RC, Ofenbacher S, Schroeder HE, et al.Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions[J]. Periodontol 2000, 1997, 14(7): 216-248. [7] Molon RS, de Avila ED, Cirelli JA. Host responses induced by different animal models of periodontal disease: a literature review[J]. J Investig Clin Dent, 2013, 4(4): 221-218. [8] de Molon RS, Park CH, Jin Q, et al. Characterization of ligature-induced experimental periodontitis[J]. Microsc Res Tech, 2018, 81(12): 1412-1421. [9] de Molon RS, Cheong S, Bezouglaia O, et al. Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model[J]. Bone, 2014, 68: 11-19. [10] de Souza JA, Nogueira AV, de Souza PP, et al. Expression of suppressor of cytokine signaling 1 and 3 in ligature-induced periodontitis in rats[J]. Arch Oral Biol, 2011, 56(10): 1120-1128. [11] Chen J, Sun Y, Mao X, et al.RANKL up-regulates brain-type creatine kinase via poly(ADP-ribose) polymerase-1 during osteoclastogenesis[J]. J Biol Chem, 2010, 285(47): 36315-36321. [12] Murata K, Fang C, Terao C, et al.Hypoxia-sensitive COMMD1 integrates signaling and cellular metabolism in human macrophages and suppresses osteoclastogenesis[J]. Immunity, 2017, 47(1): 66-79. [13] Ulland TK, Song WM, Huang SC, et al. TREM2 maintains microglial metabolic fitness in alzheimer's disease[J]. Cell, 2017, 170(4): 649-663.e13. [14] Uemura T, Ito S, Masuda T, et al.Cyclocreatine transport by SLC6A8, the creatine transporter, in HEK293 cells, a human blood-brain barrier model cell, and CCDSs patient-derived fibroblasts[J]. Pharm Res, 2020, 37(3): 61-72. [15] Cacciante F, Gennaro M, Sagona G, et al.Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of creatine transporter deficiency[J]. Sci Rep, 2020, 10(1): 18361. |